Reva Basho
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- PARP inhibition in cancer therapy
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 28
- Cancer Immunotherapy and Biomarkers 17
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 9
-
- Cancer Genomics and Diagnostics 7
- Breast Cancer Treatment Studies 7
- Co-authors
- Cuiwei Liu (2 shared papers)Xiaojiang Cui (2 shared papers)Yanxia Zhao (1 shared paper)Derick Okwan‐Duodu (1 shared paper)Constance T. Albarracin (2 shared papers)Vicente Valero (5 shared papers)Michael Z. Gilcrease (2 shared papers)Thorunn Helgason (3 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Cancer Research (7 papers)Frontiers in Oncology (2 papers)Annals of Oncology (2 papers)JAMA Oncology (1 paper)
- Partner nations
- United StatesSpainGermany
In The Last Decade
Reva Basho
33 papers receiving 536 citations
Peers
Comparison fields: 5 of 74
- Oncology 275
- Cancer Research 117
- Pulmonary and Respiratory Medicine 89
- Dermatology 23
- Infectious Diseases 46
Countries citing papers authored by Reva Basho
This map shows the geographic impact of Reva Basho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reva Basho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reva Basho more than expected).
Fields of papers citing papers by Reva Basho
This network shows the impact of papers produced by Reva Basho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reva Basho. The network helps show where Reva Basho may publish in the future.
Co-authors
The 25 scholars most cited alongside Reva Basho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 156 | |
| 2 | 2020 | 136 | |
| 3 | 2018 | 46 | |
| 4 | 2019 | 27 | |
| 5 | 2022 | 19 | |
| 6 | 2019 | 18 | |
| 7 | 2021 | 16 | |
| 8 | 2022 | 15 | |
| 9 | 2024 | 12 | |
| 10 | 2023 | 12 | |
| 11 | 2022 | 11 | |
| 12 | Clinical Applications and Limitations of Next-Generation Sequencing | 2015 | 10 |
| 13 | 2018 | 9 | |
| 14 | 2019 | 8 | |
| 15 | 2020 | 6 | |
| 16 | 2021 | 5 | |
| 17 | 2022 | 4 | |
| 18 | 2024 | 4 | |
| 19 | 2020 | 4 | |
| 20 | 2018 | 3 |
About Reva Basho
Reva Basho is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 37 papers that have together received 542 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), Cancer Treatment and Pharmacology (9 papers), HER2/EGFR in Cancer Research (9 papers), Cancer Genomics and Diagnostics (7 papers), Advanced Breast Cancer Therapies (7 papers), Breast Cancer Treatment Studies (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Oncology (275 citations), Cancer Research (117 citations), Pulmonary and Respiratory Medicine (89 citations), Dermatology (23 citations) and Infectious Diseases (46 citations). Reva Basho has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Cuiwei Liu, Xiaojiang Cui, Yanxia Zhao, Derick Okwan‐Duodu, Constance T. Albarracin, Vicente Valero, Michael Z. Gilcrease, Thorunn Helgason, Rashmi K. Murthy and Daniel D. Karp. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Frontiers in Oncology, Annals of Oncology and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.